Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Todd Neale

November 16, 2021

News Opinion CV Team Dispatch

October 2021 News Roundup

L.A. McKeown

October 01, 2021

News Daily News

Coronary Revascularization Benefits Even Latecomer STEMI: FAST-MI Registry

Michael O'Riordan

September 21, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2021

Shelley Wood

September 03, 2021

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

News Conference News ESC 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Michael O'Riordan

August 27, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

Shelley Wood

July 20, 2021

News Daily News

Hospital Stays for Meth-Related HF Skyrocket, as Do Costs

Caitlin E. Cox

July 14, 2021

News Daily News

A New Biomarker to Diagnose Acute Myocarditis?

Todd Neale

June 03, 2021

News Conference News ACC 2021

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

Todd Neale

May 18, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Daily News

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

L.A. McKeown

February 24, 2021

News Daily News

Same Drop in MI, HF Admissions Seen in COVID-19’s Second Wave

Shelley Wood

January 22, 2021

Advertisement

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

October 2021 News Roundup

Coronary Revascularization Benefits Even Latecomer STEMI: FAST-MI Registry

TCTMD’s Top 10 Most Popular Stories for August 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

Hospital Stays for Meth-Related HF Skyrocket, as Do Costs

A New Biomarker to Diagnose Acute Myocarditis?

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

May 2021 News Roundup

Pneumonia in HF Patients Is Common, Lethal, and Preventable

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

Same Drop in MI, HF Admissions Seen in COVID-19’s Second Wave

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content